Matthew P. Frosch, MD PhD
Affiliations: | Pathology | Massachusetts General Hospital and Harvard University, Boston, MA, United States |
Area:
cerebral amyloid angiopathyWebsite:
http://hst.mit.edu/public/people/faculty/facultyBiosketch.jsp?key=FroschGoogle:
"Matthew Frosch"Bio:
http://madrc.mgh.harvard.edu/matthew-p-frosch-md-phd
Cross-listing: Neurotree - Alzheimer's Tree
Children
Sign in to add trainee| Derek H. Oakley | post-doc | (Neurotree) | |
| Pavan K. Auluck | post-doc | 2004- | Massachusetts General Hospital & Harvard Medical School (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sepulveda-Falla D, Villegas Lanau CA, White C, et al. (2023) Comorbidities in Early-Onset Sporadic versus Presenilin-1 Mutation-Associated Alzheimer's Disease Dementia: Evidence for Dependency on Alzheimer's Disease Neuropathological Changes. Medrxiv : the Preprint Server For Health Sciences |
| Rajabli F, Benchek P, Tosto G, et al. (2023) Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies and nominates ancestry-specific loci , , and as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium. Medrxiv : the Preprint Server For Health Sciences |
| Gazula H, Tregidgo HFJ, Billot B, et al. (2023) 3D analysis of dissection photographs with surface scanning and machine learning for quantitative neuropathology. Biorxiv : the Preprint Server For Biology |
| Valentino RR, Scotton WJ, Roemer SF, et al. (2023) Creating the Pick's disease International Consortium: Association study of H2 haplotype with risk of Pick's disease. Medrxiv : the Preprint Server For Health Sciences |
| Merrihew GE, Park J, Plubell D, et al. (2023) A peptide-centric quantitative proteomics dataset for the phenotypic assessment of Alzheimer's disease. Scientific Data. 10: 206 |
| Kivisäkk P, Carlyle BC, Sweeney T, et al. (2023) Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment. Frontiers in Neurology. 14: 1069411 |
| Dickson JR, Frosch MP, Hyman BT. (2022) Altered localization of nucleoporin 98 in primary tauopathies. Brain Communications. 5: fcac334 |
| Ndayisaba A, Pitaro AT, Willett AS, et al. (2022) Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenotyping. Cerebellum (London, England) |
| Ndayisaba A, Pitaro AT, Willett AS, et al. (2022) Clinical Trial-Ready Patient Cohorts for Multiple System Atrophy: Coupling Biospecimen and iPSC Banking to Longitudinal Deep-Phenotyping. Cerebellum (London, England) |
| Miller MB, Huang AY, Kim J, et al. (2022) Somatic genomic changes in single Alzheimer's disease neurons. Nature |